GATA Factor Regulation of Vascular Endothelium
GATA Factor Regulation of Vascular Endothelium
批准号:
7535150
负责人:
Emery H Bresnick
金额:
$22.28万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2010-06-30
关键词:
AddressAdoptedArteriosclerosisAtherosclerosisBindingBioinformaticsBiological AssayBlood CellsBlood VesselsBoxingCell Adhesion MoleculesCell LineCell physiologyCellsCellular biologyChromatinChromosomesChromosomes, Human, Pair 3Coronary ArteriosclerosisCoupledDNADatabasesDevelopmentDiseaseE proteinElementsEmbryoEndothelial CellsEndothelin-1EndotheliumEnhancersErythroid CellsErythroid Progenitor CellsFacility Construction Funding CategoryFetal LiverFoundationsFrequenciesGene TargetingGenerationsGenesGenetic PolymorphismGenetic TranscriptionGenomeGenomicsHematopoieticHematopoietic SystemHematopoietic stem cellsHumanHybridsKnowledgeLacZ GenesLinkMeasuresMediatingMediator of activation proteinMolecular ConformationMusMutant Strains MiceNuclear ProteinNuclear ProteinsNucleic Acid Regulatory SequencesRegulationRepressionSiteSpecificitySystemTestingTranscriptional RegulationTransgenesVascular Cell Adhesion Molecule-1Vascular EndotheliumWorkadult stem cellchromatin immunoprecipitationearly onsetembryonic stem cellhuman GATA1 proteinin vivoinsightmutantnovelprospectivetranscription factor
中文摘要
描述(由申请人提供):内皮细胞特征的发展依赖于内皮细胞特异性转录机制。包括GATA-2在内的多种因子建立内皮细胞特异性转录。人类GATA2多态性与冠状动脉疾病相关,GATA-2表达与动脉硬化有关,GATA-2调节编码血管分子内皮素-1和血管粘附分子-1的基因。然而,内皮细胞中GATA-2功能和调控的机制尚不清楚。我们以小鼠造血细胞中Gata2的研究为基础,提出了阐明GATA-2在血管内皮中的功能的研究。Gata2基因座包含5个“GATA开关位点”,分别在红系前体细胞的活性位点和非活性位点上由GATA-2和GATA-1占据。gata -1介导的GATA-2从这些位点的位移与抑制相结合。+9.5位点可以自主激活小鼠胚胎和人内皮细胞内皮中的LacZ转基因,而这种活性需要结合GATA因子的DNA基序。以下目的将检验关于GATA-2在血管内皮中的功能和调控的假设:目的1 -阐明一种新的GATA因子依赖于血管内皮的转录机制。我们将测试内皮细胞中的+9.5位点增强子是否只需要GATA因子依赖的核心模块和其他调节模块。将进行染色质免疫沉淀(ChIP)和ChIP耦合微阵列芯片(ChIP- ChIP)测定,以确定内皮细胞中哪些GATA因子占据GATA2。将分析突变基因,以确定是否可以分离血管和造血特异性,以及是否可以重新编程+9.5位点以产生新的特异性。染色体构象捕获分析将用于确定GATA2在内皮细胞和造血细胞中是否采用独特的构象。将产生缺乏+9.5位点的突变小鼠,以确定其是否具有非冗余功能。目的2 -确定人内皮细胞染色体上GATA-2的靶点。只有一小部分GATA基序在红系细胞中被占据。转录因子占用的特异性尚未在内皮细胞中研究。我们将检验内皮细胞类似造血细胞的假设,因为绝大多数GATA基序没有被占用。GATA-2占用率将在内皮细胞的人类3号染色体中测量。生物信息学分析将测试e -box和其他基序是否在被占用和未被占用的GATA基序上富集,并将确定一组基因作为GATA-2功能基础电路的潜在组成部分。本项目主要研究内皮细胞和某些血细胞中表达的核蛋白GATA-2的功能和调控机制。由于GATA-2与动脉粥样硬化和冠状动脉疾病的发展有关,因此拟议的研究有望为这些人类疾病的潜在机制提供重要见解。此外,GATA-2对维持造血干细胞至关重要,因此揭示GATA-2在任何系统中的功能机制对进一步了解成体干细胞生物学具有突出的潜力。
英文摘要
DESCRIPTION (provided by applicant): The development of hallmark features of endothelial cells relies upon endothelial cell-specific transcriptional mechanisms. Multiple factors, including GATA-2, establish endothelial cell-specific transcription. Human GATA2 polymorphisms correlate with coronary artery disease, GATA-2 expression is linked to arteriosclerosis, and GATA-2 regulates genes encoding the vascular molecules endothelin-1 and vascular adhesion molecule-1. However, mechanisms underlying GATA-2 function and regulation in endothelium are unknown. Using our work on mouse Gata2 in hematopoietic cells as a foundation, studies are proposed to elucidate how GATA-2 functions in vascular endothelium. The Gata2 locus contains five "GATA switch sites" that are occupied by GATA-2 and GATA-1 at the active and inactive loci, respectively, in erythroid precursor cells. GATA-1-mediated displacement of GATA-2 from these sites is coupled to repression. The +9.5 site functions autonomously to activate a LacZ transgene in endothelium of mouse embryos and human endothelial cells, and DNA motifs that bind GATA factors are required for this activity. The following aims will test hypotheses regarding GATA-2 function and regulation in vascular endothelium: Aim 1 - To elucidate a novel GATA factor-dependent transcriptional mechanism in vascular endothelium. We will test whether the +9.5 site enhancer in endothelium uniquely requires a GATA factor- dependent core module and additional regulatory modules. Chromatin immunoprecipitation (ChIP) and ChIP coupled to microarray chip (ChIP-chip) assays will be conducted to determine which GATA factor(s) occupy GATA2 in endothelial cells. Mutant transgenes will be analyzed to determine whether vascular and hematopoietic specificities can be dissociated and whether the +9.5 site can be reprogrammed to yield novel specificities. Chromosome conformation capture analysis will be used to determine whether GATA2 adopts a unique conformation in endothelial vs. hematopoietic cells. Mutant mice lacking the +9.5 site will be generated to determine whether it functions nonredundantly. Aim 2 - To identify GATA-2 target sites on human endothelial cell chromosomes. Only a small fraction of GATA motifs are occupied in erythroid cells. The specificity of transcription factor occupancy has not been studied in endothelial cells. We will test the hypothesis that endothelial cells resemble hematopoietic cells in that the vast majority of GATA motifs are not occupied. GATA-2 occupancy will be measured throughout human chromosome 3 in endothelial cells. Bioinformatics analysis will test whether E-boxes and other motifs are enriched at occupied versus nonoccupied GATA motifs and will identify an ensemble of genes as prospective components of circuitry underlying GATA-2 function. Project Narrative This project focuses on understanding how GATA-2, a nuclear protein expressed in endothelial cells and in certain blood cells, functions and is regulated. As GATA-2 is implicated in the development of atherosclerosis and coronary artery disease, the proposed studies are expected to provide important insights into mechanisms underlying these human disorders. Furthermore, GATA-2 is crucial to maintain hematopoietic stem cells and therefore uncovering mechanisms underlying GATA-2 function in any system has outstanding potential to further knowledge on adult stem cell biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Tools to Decipher the Role of lncRNAs and Their Protein Interactomes in Hematopoiesis
-
批准号:10368117
-
项目类别:
-
资助金额:$44.43万
-
财政年份:2020
-
负责人:Emery H Bresnick
-
依托单位:
New Tools to Decipher the Role of lncRNAs and Their Protein Interactomes in Hematopoiesis
-
批准号:10570964
-
项目类别:
-
资助金额:$43.99万
-
财政年份:2020
-
负责人:Emery H Bresnick
-
依托单位:
Transcriptional Control of Hemoglobin Synthesis
-
批准号:9302889
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2016
-
负责人:Emery H Bresnick
-
依托单位:
Transcriptional Control of Hemoglobin Synthesis
-
批准号:9752268
-
项目类别:
-
资助金额:$35.97万
-
财政年份:2016
-
负责人:Emery H Bresnick
-
依托单位:
Statistical Methods For Annotating Repetitive Genomic Regions Through ENCODE-deri
-
批准号:9060461
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2012
-
负责人:Emery H Bresnick
-
依托单位:
Novel Determinants of Terminal Erythroid Maturation
-
批准号:8550827
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2012
-
负责人:Emery H Bresnick
-
依托单位:
Novel Determinants of Terminal Erythroid Maturation
-
批准号:8681511
-
项目类别:
-
资助金额:$39.12万
-
财政年份:2012
-
负责人:Emery H Bresnick
-
依托单位:
Novel Determinants of Terminal Erythroid Maturation
-
批准号:8875745
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2012
-
负责人:Emery H Bresnick
-
依托单位:
Novel Determinants of Terminal Erythroid Maturation
-
批准号:8417051
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2012
-
负责人:Emery H Bresnick
-
依托单位:
Statistical Methods For Annotating Repetitive Genomic Regions Through ENCODE-deri
-
批准号:8687990
-
项目类别:
-
资助金额:$41.55万
-
财政年份:2012
-
负责人:Emery H Bresnick
-
依托单位:
Statistical Methods For Annotating Repetitive Genomic Regions Through ENCODE-deri
-
批准号:8402305
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2012
-
负责人:Emery H Bresnick
-
依托单位:
Statistical Methods For Annotating Repetitive Genomic Regions Through ENCODE-deri
-
批准号:8546271
-
项目类别:
-
资助金额:$40.49万
-
财政年份:2012
-
负责人:Emery H Bresnick
-
依托单位:
Transcriptional Control of Hemoglobin Synthesis
-
批准号:8010054
-
项目类别:
-
资助金额:$9.93万
-
财政年份:2010
-
负责人:Emery H Bresnick
-
依托单位:
Novel Erythroid Cell Membrane Protein
-
批准号:7595979
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2009
-
负责人:Emery H Bresnick
-
依托单位:
Novel Erythroid Cell Membrane Protein
-
批准号:7851295
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2009
-
负责人:Emery H Bresnick
-
依托单位:
GATA Factor Regulation of Vascular Endothelium
-
批准号:7640615
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2008
-
负责人:Emery H Bresnick
-
依托单位:
Hematopoietic Regulation of GATA Switches
-
批准号:7169572
-
项目类别:
-
资助金额:$24.04万
-
财政年份:2006
-
负责人:Emery H Bresnick
-
依托单位:
Hematopoietic Regulation via GATA Switches
-
批准号:7986085
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2006
-
负责人:Emery H Bresnick
-
依托单位:
Hematopoietic Regulation via GATA Switches
-
批准号:8610293
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2006
-
负责人:Emery H Bresnick
-
依托单位:
Chromatin Domain Regulation in Stem Cells
-
批准号:7049832
-
项目类别:
-
资助金额:$25.42万
-
财政年份:2006
-
负责人:Emery H Bresnick
-
依托单位:
海外基金